Celltrion, Top Search Ranking... Stock Price -2.22%
As of 10:31 AM on the 30th, Celltrion is trading at 352,500 KRW, down 2.22% from the previous day. This represents a 12.64% decrease compared to December 7. Celltrion is known as a protein and biopharmaceutical manufacturing company.
Today, foreigners are tentatively recorded as net sellers of 10,000 shares. Over the past five days, individual investors have net sold 661,573 shares, while foreigners and institutions have net bought 584,251 shares and 82,707 shares, respectively.
On December 29, Celltrion made headlines in the market with the announcement of the completion of the global Phase 2 clinical trial for the COVID-19 antibody treatment CT-P59.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 40s Who Kept Girlfriend's Body for a Year After Murder Sentenced to 30 Years in Prison Again on Appeal
- "Striking Will Lead to Regret": Hyundai-Kia Employees Speak Out... Uneasy Stares Toward Samsung Union
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
